Intellectual Property as the foundation of Pharmaceutical Innovation
By Krishna Kanumuri, CEO & MD, Sai Life Sciences
Intellectual property has and will be the foundation of pharmaceutical innovation. Now, more than ever before, we are poised for a revolution in the near term with the emergence of new modes of treatment, advanced diagnostics, and digital health. The debate on drug prices and the role of intellectual property have been historically shown in an unfavourable light.
This is in good measure, due to two factors:
• established pharma companies controlling majority of new product launches
• the relative durability of therapeutic superiority of products.
However, this is changing.